AI Article Synopsis

  • Annual albuminuria screening is crucial for early nephropathy detection in diabetes patients, with guidelines recommending annual tests for type 2 diabetes and for those with type 1 after 5 years.
  • At the Eskind Diabetes Clinic, testing rates were low due to the absence of a structured approach, prompting quality improvement interventions involving electronic health record dashboards and daily staff reminders.
  • Following these interventions, annual testing rates significantly increased from 69% to 82% in six months, suggesting that similar strategies could enhance testing rates in other clinics and improve overall patient outcomes.

Article Abstract

Background: Annual albuminuria screening detects the early stages of nephropathy in individuals with diabetes. Because early detection of albuminuria allows for interventions that lower the risk of developing chronic kidney disease, guidelines recommend annual testing for all individuals with type 2 diabetes mellitus and for those with type 1 diabetes for at least 5 years. However, at the Eskind Diabetes Clinic at the Vanderbilt University Medical Center, testing occurred less frequently than desired.

Methods: A quality improvement team first analysed the clinic's processes, identifying the lack of a systematic approach to testing as the likely cause for the low rate. The team then implemented two successive interventions in a pilot of patients seen by nurse practitioners in the clinic. In the first intervention, staff used a dashboard within the electronic health record while triaging each patient, pending an albuminuria order if testing had not been done within the past year. In the second intervention, clinic leadership sent daily reminders to the triage staff. A statistical process control chart tracked monthly testing rates.

Results: After 6 months, annual albuminuria testing increased from a baseline of 69% to 82%, with multiple special-cause signals in the control chart.

Conclusions: This project demonstrates that a series of simple interventions can significantly impact annual albuminuria testing. This project's success likely hinged on using an existing workflow to systematically determine if a patient was due for testing and prompting the provider to sign a pended order for an albuminuria test. Other diabetes/endocrinology and primary care clinics can likely implement a similar process and so improve testing rates in other settings. When coupled with appropriate interventions to reduce the development of chronic kidney disease, such interventions would improve patient outcomes, in addition to better adhering to an established quality metric.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804706PMC
http://dx.doi.org/10.1136/bmjoq-2021-001591DOI Listing

Publication Analysis

Top Keywords

annual albuminuria
16
albuminuria testing
12
testing
10
testing individuals
8
individuals diabetes
8
chronic kidney
8
kidney disease
8
type diabetes
8
albuminuria
7
diabetes
5

Similar Publications

Rationale & Objective: Longitudinal research on chronic kidney disease (CKD) in sub-Saharan Africa is sparse, especially among people living with HIV (PLWH). We evaluated the incidence of CKD among PLWH compared with HIV-uninfected controls in Tanzania.

Study Design: Prospective cohort study.

View Article and Find Full Text PDF

Significant health and socio-economic challenges are posed by renal diseases, leading to millions of deaths annually. The costs associated with treating and caring for patients with renal diseases are considerable. Current therapies rely on synthetic drugs that often come with side effects.

View Article and Find Full Text PDF

Background: Diabetic nephropathy (DN) is a common complication of diabetes, which is prone to develop into end-stage renal disease, and early diagnosis and treatment is the key to effective management of DN. Biomarkers have important clinical significance in the diagnosis and treatment of DN and have attracted extensive attention from researchers in recent years. The aim of this study was to visualize the field of biomarker research in DN through bibliometric analysis, to summarize the current status and predict future trends of this field, with a view to providing valuable insights for scholars and policy makers.

View Article and Find Full Text PDF

Background: Guidelines currently recommend annual screening for albuminuria only among persons with diabetes mellitus (DM). There is no guidance about albuminuria screening in those with other important risk factors for chronic kidney disease (CKD), such as hypertension and/or family history of kidney disease. We sought to create a risk score that predicts the likelihood of albuminuria in adults without diabetes to prompt earlier detection and management of CKD.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic kidney disease (CKD) is commonly underdiagnosed and undertreated in primary care, and an electronic clinical decision support (CDS) system may enhance its detection and management.
  • The study is a 24-month randomized controlled trial involving 66 healthcare centers in Stockholm, comparing a new CDS system with existing methods to improve CKD screening, diagnosis, and management.
  • Key outcomes include the number of patients screened for kidney function, the rate of lab retesting in at-risk patients, and improved clinical diagnosis and referral rates for nephrology care.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!